Viropro lands deal to acquire Alpha Biologics
US contract research and manufacturing services firm, Viropro, has signed a $21m (€15.3m) deal for the acquisition of Malaysia-based Alpha Biologics.
US contract research and manufacturing services firm, Viropro, has signed a $21m (€15.3m) deal for the acquisition of Malaysia-based Alpha Biologics.
Elan has inked a strategic collaboration with PPD to support simultaneous advancement of multiple clinical development programmes.
Sanofi-aventis has received an FDA warning letter after the agency identified violations of cGMP at its Frankfurt am Main, Germany plant.
Mass-market drug manufacturers can turn a fixed cost into a service-providing revenue generator by investing in an agile supply chain, says PwC.
Clariant International has set up a unit to help the pharma sector overcome regulatory hurdles involved with developing colour packaging